Partners Stephen Larson and Adam Powell authored “FTC v. Endo Pharms., Inc.: The D.C. District Court ‘Treads [the] Tenuous Line Between Patent and Antitrust Laws’ to Reject the FTC’s Challenge of an Exclusive License That Allegedly Discouraged Competition,” which was published in The AIPLA Antitrust News, a publication of the AIPLA Committee on Antitrust Law.
Read the full article here.
![FTC v. Endo Pharms., Inc.: The D.C. District Court “Treads [the] Tenuous Line Between Patent and Antitrust Laws” to Reject the FTC’s Challenge of an Exclusive License That Allegedly Discouraged Competition Headshot](https://knobbemartensip.com/wp-content/uploads/2019/11/Larson-Stephen-HI-2018-09-24-300x200.jpg)
Stephen Larson has extensive experience litigating high-stakes cases in a wide variety of technology areas, including medical devices, biotechnology, software, chemistry, electronics, semiconductors, and pharmaceuticals. Stephen handles cases involving patent,...
![FTC v. Endo Pharms., Inc.: The D.C. District Court “Treads [the] Tenuous Line Between Patent and Antitrust Laws” to Reject the FTC’s Challenge of an Exclusive License That Allegedly Discouraged Competition Headshot](https://knobbemartensip.com/wp-content/uploads/2019/09/Powell-Adam-HI-2015-08-01-300x197.jpg)
Clients turn to Adam Powell to handle their most technically complex issues in the medical device, electronics, pharmaceuticals, and biotechnology industries. He is the co-chair of Knobbe Martens’ Antitrust group...
